All stock lists
NovoCure Ltd (NASDAQ:NVCR)
CH · Delayed Price · Currency is USD
Healthcare · Medical - Devices
14.61+1.18 (+8.79%)
Market cap
$1.71B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 2, 2015
Website
Insider Score
––Not scored
NVCR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NVCR analyst forecast
NVCR analyst consensus
Moderate Buy2 ratings
Buy 1 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
NVCR 12-month price target
No published price targets in the last 12 months.
NVCR ratings mix, last 12 months
Buy Hold Sell
Best analysts covering NVCR
- Evercore ISI Group50%success rate · -9.7% avg return · 2 calls
- HC Wainwright & Co.23%success rate · -32.7% avg return · 13 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
NVCR analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-10-30 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-10-30 |
| — | Wedbush | Neutral | — | — | Reiterated | 2026-07-24 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-06-18 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-05-04 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-05-01 |
| — | Wedbush | Neutral | — | — | Reiterated | 2026-04-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-02-26 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-02-12 |
| — | Wedbush | Neutral | — | — | Reiterated | 2026-01-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-01-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-10-30 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-10-27 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2025-07-25 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-06-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-04-23 |
| — | Wedbush | Neutral | — | — | Reiterated | 2025-04-16 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-04-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-14 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-12-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-02 |
| — | Evercore ISI Group | Outperform | — | — | Upgraded | 2024-12-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-21 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-10-31 |
| — | HC Wainwright & Co. | Buy | — | — | Upgraded | 2024-10-16 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2024-10-01 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2024-07-26 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2024-07-26 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2024-07-02 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2024-06-04 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2024-05-02 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-04-10 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2024-04-03 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2024-03-27 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-03-19 |
| — | HC Wainwright & Co. | Neutral | — | — | Reiterated | 2024-03-12 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2024-02-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-02-22 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2023-08-29 |
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2023-08-28 |
| — | Piper Sandler | Overweight | — | — | Upgraded | 2023-08-08 |
| — | Evercore ISI Group | In Line | — | — | Upgraded | 2023-07-31 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2023-07-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-07-27 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2023-06-07 |
| — | Wedbush | Neutral | — | — | Upgraded | 2023-06-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-06-06 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-06-06 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2023-05-16 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-05-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-04 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2023-03-17 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2023-01-17 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-01-06 |
| — | Wells Fargo | Equal Weight | — | — | Downgraded | 2023-01-06 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2022-11-29 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-10-28 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2022-10-28 |
NVCR earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | -0.41 | -0.22 | $174.4M | $174.3M |
| 2026-04-30 | -0.51 | -0.62 | $167.8M | $174.1M |
| 2026-07-23 | -0.33 | -0.13 | $172.4M | $183.6M |
| 2026-10-29 | -0.23 | -0.09 | $182.3M | $193.4M |
| 2027-02-25Upcoming | -0.21 | — | $190.2M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.